Your browser is no longer supported. Please, upgrade your browser.
Settings
ATXI [NASD]
Avenue Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.24 Insider Own1.20% Shs Outstand16.56M Perf Week-5.45%
Market Cap26.50M Forward P/E- EPS next Y-0.22 Insider Trans-2.23% Shs Float6.63M Perf Month-7.69%
Income-4.00M PEG- EPS next Q-0.05 Inst Own6.90% Short Float4.20% Perf Quarter-39.30%
Sales- P/S- EPS this Y81.10% Inst Trans-37.15% Short Ratio1.97 Perf Half Y-73.47%
Book/sh0.04 P/B39.00 EPS next Y4.30% ROA-147.90% Target Price- Perf Year-85.70%
Cash/sh- P/C- EPS next 5Y- ROE-205.90% 52W Range1.50 - 11.34 Perf YTD-73.78%
Dividend- P/FCF- EPS past 5Y13.00% ROI- 52W High-86.24% Beta0.63
Dividend %- Quick Ratio2.20 Sales past 5Y- Gross Margin- 52W Low4.00% ATR0.09
Employees4 Current Ratio2.20 Sales Q/Q- Oper. Margin- RSI (14)36.79 Volatility5.64% 5.93%
OptionableNo Debt/Eq0.00 EPS Q/Q50.00% Profit Margin- Rel Volume0.23 Prev Close1.58
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume141.00K Price1.56
Recom3.00 SMA20-7.31% SMA50-11.52% SMA200-63.11% Volume32,266 Change-1.27%
Aug-26-21 11:04AM  
Jun-21-21 08:04AM  
Jun-14-21 08:42AM  
07:44AM  
07:00AM  
Apr-26-21 08:09AM  
Apr-23-21 11:36PM  
09:43AM  
08:41AM  
Apr-22-21 10:59AM  
Apr-21-21 10:34PM  
09:38AM  
Apr-19-21 10:09PM  
06:26AM  
Apr-16-21 11:25PM  
Apr-14-21 10:34PM  
Apr-13-21 11:30PM  
03:09PM  
02:30PM  
09:33AM  
06:30AM  
Apr-12-21 01:36AM  
Jan-11-21 11:32PM  
Jan-06-21 09:23AM  
Dec-18-20 08:00AM  
08:00AM  
Dec-17-20 04:27PM  
07:00AM  
Nov-13-20 05:28AM  
Oct-28-20 07:45PM  
Oct-23-20 10:00PM  
Oct-14-20 08:58PM  
10:10AM  
Oct-13-20 01:29PM  
Oct-12-20 01:35PM  
12:45PM  
10:47AM  
06:30AM  
Sep-09-20 08:00AM  
Aug-17-20 10:33AM  
Aug-14-20 07:30AM  
Aug-04-20 12:53PM  
Jul-28-20 05:50PM  
Jul-22-20 05:50PM  
Jul-21-20 08:30AM  
Jul-16-20 05:50PM  
Jul-09-20 05:50PM  
11:30AM  
Jul-07-20 11:50AM  
Jun-29-20 08:30AM  
Jun-25-20 08:44AM  
Jun-24-20 12:00PM  
11:18AM  
Jun-23-20 10:38AM  
Jun-18-20 10:12AM  
08:50AM  
Jun-17-20 11:30AM  
Jun-16-20 08:37AM  
Jun-15-20 10:00AM  
Jun-11-20 08:55AM  
08:41AM  
Jun-10-20 08:31AM  
Jun-09-20 09:41AM  
Jun-08-20 08:25AM  
Jun-05-20 08:30AM  
May-29-20 11:33AM  
10:31AM  
08:30AM  
May-28-20 09:13AM  
May-27-20 12:43PM  
11:30AM  
09:40AM  
May-26-20 10:44AM  
10:43AM  
08:54AM  
May-22-20 08:42AM  
06:50AM  
May-11-20 07:30AM  
Apr-27-20 09:48AM  
Apr-24-20 11:07AM  
Apr-23-20 09:14AM  
08:30AM  
07:25AM  
Apr-16-20 12:00PM  
Mar-30-20 07:30AM  
Feb-13-20 08:00AM  
Dec-13-19 08:10AM  
Dec-11-19 08:30AM  
Nov-04-19 07:30AM  
Oct-28-19 08:30AM  
Oct-18-19 08:30AM  
Aug-14-19 07:30AM  
Aug-01-19 08:00AM  
Jun-07-19 01:51PM  
Jun-03-19 12:05PM  
07:00AM  
May-13-19 07:30AM  
Apr-30-19 07:30AM  
Mar-12-19 07:30AM  
Feb-11-19 07:30AM  
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vazzano Joseph WalterChief Financial OfficerSep 15Sale1.627,16011,59965,252Sep 15 04:03 PM
Herskowitz NeilDirectorMay 06Buy3.992,5009,975134,724May 07 08:02 AM